Episode summary
Hedge Fund Tips with Tom Hayes - VideoCast - Episode 366 - October 21, 2026
Summary
Tom Hayes argued that the market is in a major rotation away from the crowded AI and semiconductor trade and toward the “other 490” stocks in the S&P 500. He said the recent selloff in chips, memory, and AI infrastructure names may produce a short bounce, but the risk/reward is poor after huge run-ups, record credit stress in parts of the AI ecosystem, and rising skepticism about the cash flows needed to justify the buildout.
He framed the next 12 to 18 months as a period where earnings growth broadens beyond the MAG 7, with more benefit accruing to AI beneficiaries than to AI cost centers. In his view, staples, healthcare, small caps, and select industrials and consumer names can outperform as yields stop rising, fiscal restraint improves, and investors look for businesses with free cash flow and margin expansion rather than the most crowded theme.
Hayes also cautioned that another Fed hike or a yield-curve inversion could pressure risk assets, but he said defensives and cash-generative stocks should still hold up in a slowdown. He highlighted Baxter International, Pfizer, VF Corp., and Diageo as examples of stocks with upside and more protection on the downside.
Key takeaways
- Tom Hayes thinks the AI and semiconductor trade can bounce short term, but its risk/reward is poor after a long stretch of crowding and leverage.
- Hayes says the broader market rotation is already underway, with earnings growth outside the MAG 7 expected to overtake the leaders for the first time since 2022.
- He argues that healthcare, staples, small caps, and select industrials are better ways to play AI adoption because they can gain margin without funding huge capex.
- Hayes says rising AI credit stress and skepticism about hyperscaler free cash flow make the most crowded names vulnerable if financing tightens.
- He thinks a Fed hike would matter less now that the 10-year yield has stopped rising, while yield-curve inversion would be the main macro risk to watch.
- Hayes favors Baxter International, Pfizer, VF Corp., and Diageo as examples of names with valuation support and turnaround or defensive upside.
Notable quotes
“the next 12 to 18 months is going to be the AI beneficiaries and I think that the 490 rally, the rally in the 490 will hold up the indices”
“I don't think I would be an aggressive buyer into this right just yet”
“the numbers aren't footing. So, is this the end of the AI trade? Absolutely not”
“Our framework is huge margin of safety well above average expected forward IRR not not rear view look mirror looking”
Topics
- stock market sentiment
- market outlook
- trading strategy
- investing basics
Companies and tickers mentioned
- Great Hill Capital
Watch the episode
Watch “Hedge Fund Tips with Tom Hayes - VideoCast - Episode 366 - October 21, 2026” on YouTube
Summary, takeaways and quote selection by Octagon. Quotes are short excerpts; the full conversation is in the episode.
More from Hedge Fund Tips Tom Hayes
-
Tom Hayes - Channel NewsAsia - CNA Singapore TV Appearance - 11/16/2026 -
Hedge Fund Tips with Tom Hayes - VideoCast - Episode 369 - November 12, 2026 -
Tom Hayes - Business Peer Network - Investment Workshop - 11/5/26 -
Tom Hayes - Schwab Network Appearance - 11/4/2026 -
Tom Hayes - Fox Business - Big Money Show Appearance - 11/4/26 -
Tom Hayes - NYSE TV Appearance - 11/4/2026
Hedge Fund Tips Tom Hayes, this episode and its artwork belong to their owners. Octagon is not affiliated with the show; this page is an independent summary.